Possible link between unique chemokine and homing receptor expression at diagnosis and relapse location in a patient with childhood T-ALL

被引:21
作者
Annels, NE
Willemze, AJ
van der Velden, VHJ
Faaij, CMJM
van Wering, E
Sie-Go, DMDS
Egeler, RM
van Tol, MJD
Révész, T
机构
[1] Leiden Univ, Med Ctr, Dept Paediat, Div Immunol Haematol Oncol BMT & Autoimmune Dis, NL-2300 RC Leiden, Netherlands
[2] Erasmus Univ, Med Ctr, Dept Immunol, Rotterdam, Netherlands
[3] DCOG, The Hague, Netherlands
[4] Univ Utrecht, Med Ctr, Dept Pathol, Utrecht, Netherlands
[5] Univ Utrecht, Med Ctr, Dept Paediatr Haematol & Stem Cell Transplantat, Utrecht, Netherlands
关键词
D O I
10.1182/blood-2003-06-1812
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Childhood acute lymphoblastic leukemia (ALL) is often associated with extramedullary infiltration by leukemic cells at diagnosis or at relapse. To understand the mechanisms behind the dissemination of T-cell ALL (T-ALL) cells this study investigated the homing receptor expression on the blast cells of 11 pediatric T-ALL patients at diagnosis. One patient revealed a unique profile with high expression of the chemokine receptor CCR9 and the integrin CD103 on the T-ALL cells. Both of these molecules are specifically associated with homing to the gut. This finding was clinically significant as the patient later suffered a relapse that was confined to the gut. lmmunohistochemistry revealed that the leukemic cells in the gut still expressed CCR9 and colocalized with a high expression of the CCR9 ligand, CCL25. These findings suggest that the original expression of CCR9 and CD103 on the leukemic cells contributed to the relapse location in the gut of this patient. (C) 2004 by The American Society off Hematology.
引用
收藏
页码:2806 / 2808
页数:3
相关论文
共 17 条
  • [1] Aberrant chemokine receptor expression and chemokine production by Langerhans cells underlies the pathogenesis of Langerhans cell histiocytosis
    Annels, NE
    da Costa, CET
    Prins, FA
    Willemze, A
    Hogendoorn, PCW
    Egeler, RM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (10) : 1385 - 1390
  • [2] ORGAN SELECTIVITY FOR IMPLANTATION SURVIVAL AND GROWTH OF B-16 MELANOMA VARIANT TUMOR LINES
    FIDLER, IJ
    NICOLSON, GL
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1976, 57 (05): : 1199 - 1202
  • [3] HUJANEN ES, 1985, CANCER RES, V45, P3517
  • [4] Kleeff J, 1999, INT J CANCER, V81, P650, DOI 10.1002/(SICI)1097-0215(19990517)81:4<650::AID-IJC23>3.0.CO
  • [5] 2-#
  • [6] Functional response of leukaemic blasts to stromal cell-derived factor-1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemia
    Möhle, R
    Schittenhelm, M
    Failenschmid, C
    Bautz, F
    Kratz-Albers, K
    Serve, H
    Brugger, W
    Kanz, L
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (03) : 563 - 572
  • [7] Involvement of chemokine receptors in breast cancer metastasis
    Müller, A
    Homey, B
    Soto, H
    Ge, NF
    Catron, D
    Buchanan, ME
    McClanahan, T
    Murphy, E
    Yuan, W
    Wagner, SN
    Barrera, JL
    Mohar, A
    Verástegui, E
    Zlotnik, A
    [J]. NATURE, 2001, 410 (6824) : 50 - 56
  • [8] Chemokines and the molecular basis of cancer metastasis.
    Murphy, PM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (11) : 833 - 835
  • [9] PARACRINE AND AUTOCRINE GROWTH MECHANISMS IN TUMOR-METASTASIS TO SPECIFIC SITES WITH PARTICULAR EMPHASIS ON BRAIN AND LUNG METASTASIS
    NICOLSON, GL
    [J]. CANCER AND METASTASIS REVIEWS, 1993, 12 (3-4) : 325 - 343
  • [10] CHEMOTHERAPY IN 998 UNSELECTED CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA PATIENTS - RESULTS AND CONCLUSIONS OF THE MULTICENTER TRIAL ALL-BFM-86
    REITER, A
    SCHRAPPE, M
    LUDWIG, WD
    HIDDEMANN, W
    SAUTER, S
    HENZE, G
    ZIMMERMANN, M
    LAMPERT, F
    HAVERS, W
    NIETHAMMER, D
    ODENWALD, E
    RITTER, J
    MANN, G
    WELTE, K
    GADNER, H
    RIEHM, H
    [J]. BLOOD, 1994, 84 (09) : 3122 - 3133